- November 3, 2021
- Patient Story
In a recent conversation with the Child Neurology Foundation, Kathie Bishop, Acadia’s Senior Vice President, Head of Rare Disease and External Innovation, shared her perspective on the latest innovations in treating childhood rare diseases, such as Rett syndrome.
“At Acadia, we really try to listen. It’s so important that we have that open mind – to listen to both what the community is telling us about their disease and their journey, but also listen to what is needed. And then we try to be responsive to that.”
Kathie Bishop, Ph.D., Senior Vice President, Head of Rare Disease and External Innovation
Visit the Child Neurology Foundation’s website to read more from Dr. Bishop on what it takes to lead cutting-edge therapeutics for neurologic and rare diseases from research to development to changing lives for patients and their families.
